about
Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance.Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor.Electrolytic ablation enables cancer cell targeting through pH modulationTranscatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Advances in management of hepatocellular carcinoma.
@en
Advances in management of hepatocellular carcinoma.
@nl
type
label
Advances in management of hepatocellular carcinoma.
@en
Advances in management of hepatocellular carcinoma.
@nl
prefLabel
Advances in management of hepatocellular carcinoma.
@en
Advances in management of hepatocellular carcinoma.
@nl
P1476
Advances in management of hepatocellular carcinoma.
@en
P2093
Manon Allaire
P304
P356
10.1097/CCO.0000000000000378
P577
2017-05-15T00:00:00Z